Lack of Relationship Between Myasthenia Gravis and COVID-19 Severity

Authors

  • Rasha Moussallem Kansas University Medical Center
  • Mazen Dimachkie
  • Yessar Hussain
  • Kelly Gwathmey
  • Hani Kushlaf
  • Thy Nguyen
  • Shaida Khan
  • Rocio Garcia Santibanez
  • Husam Sultani
  • Aziz Shaibani

DOI:

https://doi.org/10.17161/rrnmf.v5i3.22260

Metrics

File downloads
41

Downloads

References

Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of Myasthenia Gravis. Neurol Clin. 2018 May;36(2):311-337. doi:10.1016/j.ncl.2018.01.011. Review. PMID:29655452

Rivner MH, Pasnoor M, Dimachkie MM, Barohn RJ, Mei L. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004. Review.PMID:29655451

Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ. Diagnosis of Myasthenia Gravis. Neurol Clin. 2018 May;36(2):261-274. doi: 10.1016/j.ncl.2018.01.010. Review. PMID:29655449

Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155-162. doi:10.1097/BOR.0000000000000776

Howard J. CLINICAL OVERVIEW OF MG. CLINICAL OVERVIEW OF MG. Published June 2015. https://myasthenia.org/Professionals/Clinical-Overview-of-MG

Solé G, Mathis S, Friedman D, et al. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis. Neurology. 2021;96(16):e2109-e2120. doi:10.1212/WNL.0000000000011669

Jakubíková M, Týblová M, Tesař A, et al. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol. 2021;28(10):3418-3425. doi:10.1111/ene.14951

Muppidi S, Guptill JT, Jacob S, et al. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020;19(12):970-971. doi:10.1016/S1474-4422(20)30413-0

Camelo-Filho AE, Silva AMS, Estephan EP, et al. Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes. Front Neurol. 2020;11:1053. doi:10.3389/fneur.2020.01053

Anand, P. et al. (2020) “COVID‐19 in patients with Myasthenia Gravis,” Muscle & Nerve, 62(2), pp. 254–258. Availale at: https://doi.org/10.1002/mus.26918.

Jacob, S., Muppidi, S., Guidon, A., Guptill, J., Hehir, M., Howard, J. F., Illa, I., Mantegazza, R., Murai, H., Utsugisawa, K., Vissing, J., Wiendl, H., & Nowak, R. J. (2020). Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. Journal of the Neurological Sciences, 412, 116803. https://doi.org/10.1016/j.jns.2020.116803

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242

Pizzamiglio C, Pitceathly RDS, Lunn MP, Brady S, De Marchi F, Galan L, Heckmann JM, Horga A, Molnar MJ, Oliveira ASB, Pinto WBVR, Primiano G, Santos E, Schoser B, Servidei S, Sgobbi Souza PV, Venugopalan V, Hanna MG, Dimachkie MM, Machado PM; Neuromuscular Diseases and COVID-19 Study Group. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry. Eur J Neurol. 2023 Feb;30(2):399-412. doi: 10.1111/ene.15613. Epub 2022 Nov 18. PMID: 36303290; PMCID: PMC9874570.

Sadjadi R, Conaway M, Cutter G, Sanders DB, Burns TM; MG Composite MG-QOL15 Study Group. Psychometric evaluation of the myasthenia gravis composite using Rasch analysis. Muscle Nerve. 2012 Jun;45(6):820-5. PMID: 22581534

Porras, L., Homeded, C., Maria Emanuela Alberti, Santamaria, V., & Casasnovas, C. (2022). Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales. 11(8), 2189-2189. https://doi.org/10.3390/jcm11082189

Gungor Tuncer, O., & Deymeer, F. (2022). Clinical course and outcome of an outpatient clinic population with myasthenia gravis and covid‐19. Muscle & Nerve, 65(4), 447–452. https://doi.org/10.1002/mus.27497

Zhou Y, Yang J, Xu C, Hu C, Lu F, Xue F, Zhang P. The Effects of Diabetes and Hypertension on the Severity of COVID-19 - Yichang, Hubei Province, 2020. China CDC Wkly. 2020 Oct 23;2(43):833-837. doi: 10.46234/ccdcw2020.135. PMID: 34594777; PMCID: PMC8393137.

Downloads

Published

2024-12-17

Issue

Section

New Discoveries and Original Research

How to Cite

Moussallem, R., Dimachkie, M., Hussain, Y., Gwathmey, K., Kushlaf, H., Nguyen, T., Khan, S., Garcia Santibanez, R., Sultani, H. ., & Shaibani, A. (2024). Lack of Relationship Between Myasthenia Gravis and COVID-19 Severity. RRNMF Neuromuscular Journal, 5(3). https://doi.org/10.17161/rrnmf.v5i3.22260